StereoEEG Motor Neuronal Potentials Decoding

Launched by RESEARCH CENTER OF NEUROLOGY, RUSSIA · May 22, 2024

Keywords

ClinConnect Summary

This clinical trial is exploring how to better understand brain signals related to movement in patients with drug-resistant epilepsy who have already had special brain electrodes implanted for medical reasons. The main goal is to evaluate how accurately these brain signals can be interpreted to potentially help develop new brain-computer interfaces (BCIs) that could assist with movement control. Participants will take part in a single session where their brain signals will be recorded while they perform tasks like moving their hands or imagining movements. This session will last no more than an hour and will be conducted in a safe environment, ensuring that the activities do not trigger any seizures.

To be eligible for the trial, participants must be between 18 and 70 years old and have the implanted electrodes for their epilepsy treatment. They should be able to understand and follow instructions during the study. However, those with certain conditions, like severe visual impairments or significant motor issues, cannot participate. This study aims to gather valuable information that could lead to advancements in how we interpret brain activity, potentially improving treatments for those with movement challenges.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • male and female patients who have had stereoEEG electrodes implanted for medical reasons;
• • voluntary informed consent to participate in the study;
• • age from 18 to 70 years.
• Exclusion Criteria:
• • patient refusal to participate in the study;
• • cognitive impairment that prevents following the study instructions;
• • severe visual impairment that does not allow viewing visual instructions on a computer screen;
• • upper limb paresis or other motor disorders;
• • pain in the hand of any etiology;
• • any acute diseases, exacerbation of chronic diseases, acute life-threatening conditions;
• • occurrence of an epileptic attack during the experiment.